A team at Shift Bioscience employs a novel single-cell transcriptomic clock (AC3) to screen 1,500 genes, discovering SB000 as a single-factor intervention that reverses transcriptomic and epigenetic aging in fibroblasts and keratinocytes without activating pluripotency, paving the way for safe rejuvenation therapies.
Key points
- AC3 single-cell transcriptomic clock screens 1,500 ORFs to identify rejuvenation factors.
- SB000 expression reduces transcriptomic age by ~4.5 years in fibroblasts and keratinocytes without pluripotency.
- SB000 reverses multiple epigenetic clocks and increases global CpG methylation by ~3%, preserving cell identity.
Why it matters: SB000 decouples cell rejuvenation from pluripotency, offering a safer, single-gene route to reverse aging across diverse tissues.
Q&A
- What is SB000?
- How does the AC3 transcriptomic clock work?
- Why avoid pluripotency for rejuvenation?
- What evidence shows SB000 reverses epigenetic aging?